Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • Peer reviewer login
  • Alerts
  • Subscriptions

Hypoperfusion is the main risk factor for the development of non-tuberculous mycobacterial lung disease in CTEPH

Monika Szturmowicz, Karina Oniszh, Ewelina Wilinska, Aneta Kacprzak, Ewa Augustynowicz-Kopec, Marcin Kurzyna, Maria Wieteska, Adam Torbicki, Jan Kus
European Respiratory Journal 2013 42: P2605; DOI:
Monika Szturmowicz
1I Department of Lung Diseases, National Institute of Tuberculosis and Lung Diseases, Warsaw, Poland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Karina Oniszh
2Department of Radiology, National Institute of Tuberculosis and Lung Diseases, Warsaw, Poland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ewelina Wilinska
1I Department of Lung Diseases, National Institute of Tuberculosis and Lung Diseases, Warsaw, Poland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aneta Kacprzak
1I Department of Lung Diseases, National Institute of Tuberculosis and Lung Diseases, Warsaw, Poland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ewa Augustynowicz-Kopec
3Department of Microbiology, National Institute of Tuberculosis and Lung Diseases, Warsaw, Poland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marcin Kurzyna
4Department of Cardiology, European Center of Health, Otwock, Poland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maria Wieteska
4Department of Cardiology, European Center of Health, Otwock, Poland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Adam Torbicki
4Department of Cardiology, European Center of Health, Otwock, Poland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jan Kus
1I Department of Lung Diseases, National Institute of Tuberculosis and Lung Diseases, Warsaw, Poland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Abstract

Non-tuberculous mycobacterial lung disease (NTMLD) is diagnosed in 3-6% of patients (pts) with predisposing chronic lung diseases such as COPD and cystic fibrosis. We reported previously the occurrence of NTMLD due to M. kansasii in 6/156 CTEPH pts (3.8%) treated in our centre from 2002 to 2008. The aim of the present study was to analyse the possible causes of NTMLD development in CTEPH pts.

Methods: Clinical data, chest CT scans and hemodynamic variables of 156 CTEPH pts were analysed. Reconstructions were obtained to allow for better visualisation of lung density on chest CT scan.

Results: Marked mosaic perfusion of grade 3-4 was significantly more frequent on CT scans in CTEPH pts who developed NTMLD in comparison to the others (100% vs 64%, p=0.024). Moreover NTMLD, described as focal consolidations with cavitation and satelite micronodules, developed in the areas of lung hypoperfusion.

Pulmonary artery diameter on chest CT scan was 40 (36-42) mm in NTMLD pts comparing to 35 (26 -62) mm in the remaining ones (p=0.015).

CTEPH patients with NTMLD were slimmer than the others: BMI were 23.4 (17.6-27.7) kg/m2 and 28.45 (15.6-55.1) kg/m2 respectively, p=0.039.

NTMLD pts had also lower cardiac indexes and lower mixed venous blood oxygen saturation in comparison to the group without mycobacteriosis.

Conclusions: Vascular pathology resulting in the areas of hypoperfusion within the lungs is probably the reason of growing susceptibility to NTMLD in CTEPH. This phenomenon might be responsible for local defence disturbances. The disease occurrence in younger and slimmer group of CTEPH pts is also observed.

  • Pulmonary hypertension
  • Embolism
  • Comorbidities
  • © 2013 ERS
Previous
Back to top
Vol 42 Issue Suppl 57 Table of Contents
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Hypoperfusion is the main risk factor for the development of non-tuberculous mycobacterial lung disease in CTEPH
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Hypoperfusion is the main risk factor for the development of non-tuberculous mycobacterial lung disease in CTEPH
Monika Szturmowicz, Karina Oniszh, Ewelina Wilinska, Aneta Kacprzak, Ewa Augustynowicz-Kopec, Marcin Kurzyna, Maria Wieteska, Adam Torbicki, Jan Kus
European Respiratory Journal Sep 2013, 42 (Suppl 57) P2605;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Hypoperfusion is the main risk factor for the development of non-tuberculous mycobacterial lung disease in CTEPH
Monika Szturmowicz, Karina Oniszh, Ewelina Wilinska, Aneta Kacprzak, Ewa Augustynowicz-Kopec, Marcin Kurzyna, Maria Wieteska, Adam Torbicki, Jan Kus
European Respiratory Journal Sep 2013, 42 (Suppl 57) P2605;
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
  • Info & Metrics
  • PDF
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • In-situ metabolite profiling of remodeled arteries in Pulmonary Arterial Hypertension (PAH) using innovative mass spectrometry imaging (MSI) tools
  • Role of the TrkA receptor in experimental severe pulmonary hypertension
  • Role of JAK2/STAT3 pathway in vascular function of pulmonary fibrosis patients
Show more 4.3 Pulmonary Circulation and Pulmonary Vascular Disease

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society